Pharmaceutical Quality of Nine Generic Orlistat Products Compared with Xenical®

Publisher： Karger

E-ISSN： 1662-4033|3|4|231-237

ISSN： 1662-4025

Source： Obesity Facts, Vol.3, Iss.4, 2010-08, pp. : 231-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Integrated Analysis of Liver Safety Data from Orlistat Clinical Trials

By  

Obesity Facts, Vol. 5, Iss. 4, 2012-07 ,pp. : 485-494

Karger

Access to resources Recommend Favorite

Multi-Factorial Approach Associated with a New ‘On/Off’ Orlistat® Use in a Weight Loss Maintenance Programme: 4 Years Follow-Up

By  

Obesity Facts, Vol. 4, Iss. 3, 2011-05 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor

By  

Neuroendocrinology, Vol. 103, Iss. 5, 2015-08 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

Elevated Inflammation Markers in Pheochromocytoma Compared to Other Forms of Hypertension

By  

Neuroimmunomodulation, Vol. 14, Iss. 1, 2007-08 ,pp. : 57-64

Karger

Access to resources Recommend Favorite

Selling Dreams: An Overview of Slimming Products' Advertisements in Switzerland

By  

Obesity Facts, Vol. 7, Iss. 5, 2014-10 ,pp. : 282-288

Karger

Access to resources Recommend Favorite